Research Paper Volume 12, Issue 22 pp 23200—23216

Development and validation of a nomogram with an epigenetic signature for predicting survival in patients with lung adenocarcinoma

Figure 6. Relationship between the prognostic epigenetic biosignature and clinicopathological features.